• Weizmann Institute Recognized for High Performance by U-Multirank

    U-Multirank, a leading European initiative that ranks universities worldwide based on a number of key performance...

    Read more
  • A Stem of Support: PLX Stem Cells Provide COVID-19 Relief

    Pluristem was founded in 2001 by Shai Meretzki of the Technion, who made use of a stem cell patent which was developed during his...

    Read more
  • Prof Alon Harmelin and Dr. Slava Kalchenko, two Weizmann Institute scientists, developed TOVA – a innovative imaging system that can diagnose and monitor subdural hematomas frequently caused by...

    Read more
  • The Weizmann Institute and the Institute for Biological Research join hands to advance COVID-19 research.

    The Coronavirus pandemic has prompted relevant responses from organizations from...

    Read more
  • המרוץ אחר התרופה לקורונה: הצצה נדירה למעבדות של מכון וייצמן

    מאז פרוץ מגפת הקורונה במכון ויצמן שברחובות מתנהלת מלחמה נגד הנגיף, במטרה למצוא כמה שיותר מהר חיסון או תרופה...

    Read more
  • An Introduction to the Basic Complexities of Technology Transfer. Les Nouvelles, the journal of the Licensing Executives Society International (LES), recently published a fascinating article on...

    Read more
  • Ness Ziona, Israel – March 31, 2020: BiomX, a clinical stage company and a subsidiary of YEDA, the Weizmann Institute's technology transfer arm, recently announced that its positive Phase 1 data...

    Read more
  • An innovative Weizmann Institute initiative helps individuals track their sense of smell and potentially detect early signs of COVID-19.

    ...

    Read more
  • The Coronavirus pandemic is forcing us all to confront the relative lack of anti-viral treatments that humanity has in its armamentarium. At the Weizmann Institute of Science, we confront this...

    Read more
  • On January 28th, Grove Ventures launched Frontier Tech, Israel's first “Deep Tech” conference. Yeda was a major partner in organizing this groundbreaking conference, helping Grove Ventures select...

    Read more
  • Deerfield Commits up to $130 million to Advance New Medicines at Israeli Institute Through a Newly Launched Company

    (Rehovot, Israel and New York, NY, January 6, 2019) - ...

    Read more
  • Yeda, the Commercial Arm of the Weizmann Institute of Science, and Deerfield Create Orchard Innovations, LLC

    Deerfield Commits up to $130 million to Advance New Medicines at the Israeli...

    Read more
  • The prestigious Leiden ranking puts the impact of Institute research high up in a list of the top universities and research institutes 08.07.2018

    The Weizmann Institute of Science has been...

    Read more
  • Naiberg to head technology transfer at UCLA

    After 15 years at Yeda Research and Development Co. Ltd., the technology transfer arm of the Weizmann Institute of Science,...

    Read more
  • Originally printed as an advertisement feature in Nature, Vol. 533, No. 7601 (5 May 2016)

    One cannot predict what scientific discoveries or revolutions will be made in the laboratories of...

    Read more
  •  

    EAU TV spoke to Mark Emberton, UCL, and Eva Johannsen, University of Gothenburg at EAU16 about the use and limitations of active surveillance, how it affects quality of life, and a new...

    Read more
  • Tel Aviv --   February 1,  2016:   NewCO2Fuels  (NCF), an Israeli start-up which transforms CO2 emissions into a clean fuel that can be sold as a commodity at competitive prices, was anno unced as...

    Read more
  • NCF’s technology, which captures CO2 emissions and turns them into fuel, may offer an alternative to cutting back on greenhouse gases

    DAPHNE ROUSSEAU. 2015

     

    The company...

    Read more
  • Tech Republic, 2 December

    http://www....

    Read more
  • ImmunArray Ltd announces the Launch of the SLE-key™ Rule Out test to be run out of VERACIS the Company’s Service Laboratory beginning in March 2015, in Richmond, Virginia Richmond, VA and Rehovot...

    Read more
  • XL-protein from Germany and Yeda, the commercial arm of the Weizmann Institute of Science, have announced the signing of a collaboration agreement for the commercial exploitation of an improved...

    Read more
  • An Israeli-Australian venture will use solar technology developed at the Weizmann Institute of Science to reduce carbon dioxide emissions from the burning of brown coal. The venture has been...

    Read more
  • 3i to Develop Microscopes of the Future Based on Weizmann Institute Inventions

    Yeda, the technology transfer arm of the Weizmann Institute of Science, has signed a license agreement with ’...

    Read more
  • Janssen Research & Development announced several new collaborations through its Janssen Human Microbiome Institute (JHMI) focused on advancing the discovery, development and commercialization...

    Read more
  • Prolor received approval for a new patent by the Patent Authority in the U.S. for its RPEG platform. Prolor’s medicine for obesity and Type-2 diabetes is based on this platform.

    ...

    Read more
  • ALAMEDA, Calif.--(BUSINESS WIRE)--

    BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading...

    Read more
  • The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research and Development Co., Ltd., its commercial arm, announced this week that they have entered a multi-year arrangement with...

    Read more
  • A protocol that arose from Weizmann Institute of Science research has led to US Food and Drug Administration approval of a new biological drug for the treatment of a certain form of lung cancer....

    Read more
  • Darmstadt, Germany, and Rehovot, Israel, February 16, 2016 – Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, of...

    Read more
  • Darmstadt, Germany, and Rehovot, Israel, February 16, 2016 – Merck, a leading science and technology company, announced that the Weizmann Institute conferred the renowned Weizmann Award in the...

    Read more
  • Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico

    A therapy invented at the Weizmann Institute of Science and clinically developed...

    Read more